Enerji ve Besin Ögeleri Alımının İnsülin Direnci ve İnflamasyon Bulguları Üzerine Etkileri

Amaç: Bu araştırma, insülin direnci hastalarının enerji ve besin ögeleri alımlarının insülin ve inflamasyon bulguları üzerine etkisini saptamak amacıyla yapılmıştır. Bireyler ve Yöntem: Araştırma,30-50 yaşları arasında, ilk defa insülin direnci teşhisi konulan, Beden Kütle İndeksi (BKİ) 30-40 kg/m2 arasında olan ve hiperlipidemi dışında başka bir hastalığı bulunmayan 53 kadın hastanın katılımıyla yapılmıştır. Araştırmaya katılan hastaların bir günü hafta sonu olmak üzere 3 günlük besin tüketim kayıtları alınmıştır. Bunun yanında hastaların açlık ve tokluk glukoz, açlık ve tokluk insülin, total kolesterol, trigliserit, HDL-kolesterol, LDL-kolesterol, VLDL-kolesterol değerlerine bakılmış, HOMA-IR hesaplanmıştır. Ayrıca hastaların CRP, TNF-?, IL-1 ve IL-6 düzeylerine bakılmıştır. Bulgular: Hastaların diyetle aldıkları karbonhidrattan gelen enerji oranının (%46.5±10.4) önerilen düzeyin altında, yağ oranının (%39.3±8.9) önerilen düzeyin üzerinde olduğu belirlenmiştir. Diyetle alınan yağ miktarının (66.7±24.2 g) önerilen düzeyin çok az üzerinde olduğu bulunmuştur. Çoklu doymamış yağ asitleri oranı (%8.9±4.4), tiamin (0.6±0.2 mg), niasin (0.9±0.4 mg), folik asit (238.8±84.6 µg), kalsiyum (577.9±263.3 mg), magnezyum (222.1±94.6 mg) ve çinko (8.1±3.6 mg) alımının önerilen düzeyin altında olduğu saptanmıştır. Doymuş yağ asitleri (24.9±10.9 g) ve C vitamini (107.0±75.6 mg) miktarlarının önerilen düzeyin çok az üzerinde olduğu bulunmuştur. Enerjinin doymuş yağ (%15.1±5.9) ve tekli doymamış yağ (%13.4±4.8), asitlerinden sağlanan oranının, A vitamini (1098.9±1041.1 µg) ve fosfor (933.1±410.2 mg) miktarlarının önerilen düzeyin üzerinde olduğu belirlenmiştir. Hastaların tükettikleri karbonhidrat miktarı ile TNF-? arasında pozitif yönlü zayıf bir ilişki olduğu saptanmıştır (p=0.043, r=0.416). Diyetin karbonhidrat yüzdesi ile CRP (p=0.007, r=0.366) ve TNF-? arasında pozitif yönlü zayıf (p=0.033, r=0.437) ilişki olduğu görülmüştür. Yağ yüzdesi ile CRP arasında negatif yönlü zayıf (p=0.018, r=-0.325), TNF-? ile arasında negatif yönlü orta derecede (p=0.000, r=-0.665) bir ilişki olduğu belirlenmiştir. Alınan tiamin (p=0.014, r=0.493), potasyum (p=0.030, r=0.443) ve fosfor (p=0.027, r=0.451) miktarı ile TNF-? arasında pozitif yönlü zayıf bir ilişki olduğu saptanmıştır. Buna ek olarak alınan demir miktarı ile TNF-? arasında da pozitif yönlü orta düzeyde ilişki olduğu belirlenmiştir (p=0.004, r=0.563). Tartışma: İnsülin direnci hastalarının enerji ve besin ögeleri alımlarının insülin direnci ve inflamasyon bulguları üzerine etkisi net bir şekilde saptanamamıştır. Bunun nedeni örnek sayısının azlığı olabilir. Bu konuda daha fazla araştırma yapılmasına gerek vardır

Effects of Energy and Nutrients Intakes on Insulin Resistance and Inflammation Markers

Aim: This study aimed to determine the relationship between energy and nutrients intake of patients with insulin resistance parameters and inflammation markers. Subjects and Method: This study was conducted with participation of 53 female patients aged between 30 and 50 years, were diagnosed with insulin resistance for the first time, had a body mass index of 30-40 kg/m2, had no disease other than hyperlipidemia, in order to determine the presence of inflammation in the patients with insulin resistance. Three-day (including one weekend day) food consumption records of the patientss has been collected. Fasting and postprandial glucose, fasting and postprandial insulin, total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol values of patients were examined, and HOMA-IR values were calculated. Also CRP, TNF-α, IL-1β, and IL-6 levels of patients were examined. Results: The ratio of energy from carbohydrates (46.5%±10.4) and the ratio of polyunsaturated fatty acids (8.9%±4.4) and thiamin (0.6±0.2 mg), niacin (0.9±0.4 mg), folic acid (238.8±84.6 µg), calcium (577.9±263.3 mg), magnesium (222.1±94.6 mg) and zinc (8.1±3.6 mg) intake of patients were below the recommended levels. The ratio of fat from energy (39.3%±8.9), saturated fatty acids (15.1%±5.9) and monounsaturated fatty acids (13.4%±4.8), saturated fatty acids (24.9±10.9 g), vitamin C (107.0±75.6 mg), vitamin A (1098.9±1041.1 µg) and phosphorus (933.1±410.2 mg) intakes were above the recommended levels. There was a positive weak correlation between carbohydrate intake of patients and TNF-α (p=0.043; r=0.416) and between the ratio of carbohydrate and CRP (p=0.007; r=0.366) and TNF-α (p=0.033; r=0.437). There was a negative weak correlation between the ratio of fat percentage and CRP (p=0.018; r=-0.325). There was a negative medium correlation between the ratio of fat percentage and TNF-α (p=0.000; r=-0.665). There was a positive weak correlation between thiamin (p=0.014; r=0.493), potassium (p=0.030; r=0.443) and phosphorus (p=0.027; r=0.451) intakes and TNF-α. In addition, there was a positive medium correlation between iron intake and TNF-α (p=0.004; r=0.563). Conclusion: The relationships between energy and nutrients intake of patients with insulin resistance and insulin resistance and inflammation markers could not be clearly established, may be depending on small sample size. Further research is needed in this regard

___

  • 1. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112(12):1821-1830.
  • 2. Fernández-Real JM, Straczkowski M, Vendrell J, Soriguer F, del Pulgar SP, Gallart L, et al. Protection from inflammatory disease in insulin resistance: the role of manan-binding lectin. Diabetologia 2006;49:2402- 2411.
  • 3. Kim Y, Keogh JB, Clifton PM. Benefits of nut consumption on insulin resistance and cardiovascular risk factors: Multiple potential mechanisms of actions. Nutrients 2017; 9:1271-1310.
  • 4. Rocha DM, Bressan J, Hermsdorff HH. The role of dietary fatty acid intake in inflammatory gene expression: a critical review. Sao Paulo Med J 2017;135(2):157-168.
  • 5. Mousa A, Naderpoor N, Johnson J, Sourris K, de Courten MPJ, Wilson K, et al. Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Sci Rep 2017;7:15154-15165.
  • 6. Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: Connecting inflammation & metabolism. Biochim Biophys Acta 2015;1851(4):503-518.
  • 7. Wang H, Ye J. Regulation of energy balance by ınflammation: common theme in physiology and pathology. Rev Endocr Metab Disord 2015;16(1):47– 54.
  • 8. Jianping YJ, Keller JN. Regulation of energy metabolism by inflammation: A feedback response in obesity and calorie restriction. AGING 2010;2(6):361- 368.
  • 9. Fernández-Real JM, Vendrell J, Broch M, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003;26(5):1362-1368.
  • 10. Monfort-Pires M, Crisma AR, Bordin S, Ferreira SRG. Greater expression of postprandial inflammatory genes in humans after intervention with saturated when compared to unsaturated fatty acids. Eur J Nutr 2017 Nov 2: [E-pub ahead of print], doi: 10.1007/s00394- 017-1559-z.
  • 11. Ross AC. Adressing research questions with national survey data-the relation of vitamin A status to infection and inflammation. Am J Clin Nutr 2000;72:1069-1070.
  • 12. Vázquez LA, Pazos F, Berrazuetaz JR, FernándezEscalante C, García-Unzueta MT, Freijanes J, et al. Adipocyte Turnover: Relevance to human adipose tissue morphology. Diabetes 2010;59:105-109.
  • 13. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. JCEM 2009;94(9):3171-3182.
  • 14. Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83(suppl):1505S-1519S.
  • 15. Calder PC. Immunological Parameters: What do they mean? J Nutr 2007;137:773S-780S.
  • 16. Khayyatzadeh SS, Kazemi-Bajestani SMR, Bagherniya M, Mehramiz M, Tayefi M, Ebrahimi M, et al. Serum high C reactive protein concentrations are related to the intake of dietary macronutrients and fiber: Findings from a large representative Persian population sample. Clin Biochem 2017;50(13-14):750-755.
  • 17. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ, Li W, et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 2006;83:760-766.
  • 18. Villamor E, Fawzi WW. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 2005;18(3):446-464.
  • 19. Jialal I, Singh U. Is vitamin C an antiinflammatory agent? Am J Clin Nutr 2006;83:525-526.
  • 20. Schweigert FJ. İnflammation-induced changes in the nutritional biomarkers serum retinol and carotenoids. Curr Opin Clin Nutr Metab Care 2001;4:477-481.
  • 21. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neurimmunol 2003;134:128-132.
  • 22. Choi KM, Lee KW, Kim SG, Kim NH, Park CG, Seo HS, et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005;90(1):175-180.
  • 23. Singh U, Jialal I. Anti-inflammatory effects of α-tocopherol. Ann NY Acad Sci 2004;1031:195-203.
  • 24. Luizzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. PNAS 2005;102(19):6843-6848.
  • 25. Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism.J Physiol Sci. 2017 Sep 30 [E-pub ahead of print] doi: 10.1007/s12576-017- 0571-7
  • 26. Maktabi M, Jamilian M, Asemi Z. Magnesium-zinccalcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: A randomized, double-blind, placebocontrolled trial. Biol Trace Elem Res 2017 Jul 1 [E-pub ahead of print] doi: 10.1007/s12011-017-1085-0
  • 27. Afshar Ebrahimi F, Foroozanfard F, Aghadavod E, Bahmani F, Asemi Z. The effects of magnesium and zinc co-supplementation on biomarkers of ınflammation and oxidative stress, and gene expression related to inflammation in polycystic ovary syndrome: a randomized controlled clinical trial. Biol Trace Elem Res 2017 Nov 10 [E-pub ahead of print] doi: 10.1007/ s12011-017-1198-5
  • 28. Erhardt J (2004). BeBis: Nutrition Data Base Software. İstanbul.
  • 29. Chen D, Li X, Zhai Z, Shu HB. A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)-α and IL-induced NFκB activation. J Biol Chem 2002;277(18):15985-15991.
  • 30. Besler HT, Rakıcıoğlu N, Ayaz A, Demirel ZB, Özel HG, Samur GE, et al. Türkiye’ye Özgü Besin ve Beslenme Rehberi, 1. Baskı. Ankara, Merdiven Reklam Tanıtım; 2015.
  • 31. SPSS For Windows Release 11.0 (2004).
  • 32. Gregory H. Norris GH, Blesso CN. Dietary and endogenous sphingolipid metabolism in chronic inflammation. Nutrients 2017;9:1180-1204.
  • 33. Akamine EH, Marçal AC, Camporez JP, Hoshida MS, Caperuto LC, Bevilacqua E, et al. Obesity induced by high-fat diet promotes insulin resistance in the ovary. J Endocrinol 2010;206:65-74.
  • 34. Isharwal S, Misra A, Wasir JS, Nigam P. Diet and insulin resistance: A review and Asian Indian perspective. In J Med Res2009;129:485-499.
  • 35. Engin AB. What is lipotoxicity? Adv Exp Med Biol 2017;960:197-220.
  • 36. Figueiredo PS, Inada AC, Gabriela Marcelino G, Cardozo CML, de Cássia Freitas K, de Cássia Avellaneda Guimarães R, et al. Fatty acids consumption: the role metabolic aspects ınvolved in obesity and its associated disorders. Nutrients 2017;9:1158-1190.
  • 37. Riccardi G, Rivelles AA. Dietary treatment of the metabolic syndrome– the optimal diet. B J Nutr 2000;83(Suppl 1):S143-S148.
  • 38. Lucero D, Olano C, Bursztyn M, Morales C, Stranges A, Friedman S, et al. Supplementation with n-3, n-6, n-9 fatty acids in an insulin-resistance animal model: does it improve VLDL quality? Food Funct 2017;8(5):2053- 2061.
  • 39. Capó X, Martorell M, Sureda A, Riera J, Drobnic F, Tur JA, et al. Effects of almond- and olive oil-based docosahexaenoic- and vitamin E-enriched beverage dietary supplementation on inflammation associated to exercise and age. Nutrients 2016(8):619-637.
  • 40. Mocellin MC, Fernandes R, Chagas TR, Trindade EBSM. A meta-analysis of n-3 polyunsaturated fatty acids effects on circulating acute-phase protein and cytokines in gastric cancer. Clin Nutr 2017 May 13 [E-pub ahead of print] doi: 10.1016/j.clnu.2017.05.008.
  • 41. Lin N, Shi JJ, Li YM, Zhang XY, Chen Y, Calder PC, et al. What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis 2016;15:133-141.
  • 42. Mehmetoğlu I, Yerlikaya FH, Kurban S. Correlation between vitamin A, E, coenzyme Q (10) and degree of insulin resistance in obese and non-obese subjects. J Clin Biochem Nutr 2011;49(3):159-163.
  • 43. Rizzo MR, Abbatecola AM, Barbieri M, Vietri MT, Cioffi M, Grella R, et al. Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action. J Am Coll Nutr 2008;27(4):505-511.
  • 44. Khatami PG, Soleimani A, Sharifi N, Aghadavod E, Asemi Z. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. J Clin Lipidol 2016;10(4):922- 929.
  • 45. Manolescu DC, Sima A, Bhat PV. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J Nutr 2010;140:311-316.
  • 46. Zulet M.A, Puchau B, Hermsdorff HH, Navarro C, Martínez JA. Vitamin A intake is inversely related with adiposity in healthy young adults. J Nutr Sci Vit 2008;54(5):347-352.
  • 47. Jeyakumar SM, Vijaya Kumar P, Giridharan NV, Vajreswari A. Vitamin A improves insulin sensitivity by increasing insulin receptor phosphorylation through protein tyrosine phosphatase 1B regulation at early age in obese rats of WNIN/Ob strain. Diab Obe Metab 2011;13(10):955-958.
  • 48. Dibaba1 DT, Xun P, Fly AD, Yokota K, Hel K. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med 2014;31(11):1301–1309.
  • 49. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR, et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010;33(12):2604-2610.
  • 50. Chameroy KA, Frank N, Elliott SB, Boston RC. Effects of a supplement containing chromium and magnesium on morphometric measurements, resting glucose, insulin concentrations and insulin sensitivity in laminitic obese horses. Equi Vet J 2011;43(4):494-499.
  • 51. Sharifi F, Mazloomi S, Hajihosseini R, Mazloomzadeh S. Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance. Gyneco End 2011;28(1):7-11.
  • 52. Wood RJ, Volek JS, Davis SR, Dell’ova C, Fernandez ML. Effects of carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab 2006;3:19-30.
  • 53. Bergman M, Bessler H, Salman H, Siomin D, Straussberg R, Dialdetti M. In vitro cytokine production in patients with iron deficiency anemia. Clin Immunol 2004;113(3):340-344.
  • 54. Haase H, Rink L. Signal transduction in monocytes: the role of zinc ions. Biometals 2007;20:579-585.